Retinopathy can lead to blindness in people with diabetes and may occur far sooner than previously thought, possibly when patients are still in the prediabetes stage or when glucose levels are only slightly higher than normal.

In Controlling Lipid and Glucose Levels. The novel compound tesaglitazar (Galida) appears to be effective in reducing fasting glucose while decreasing triglyceride levels and increasing high-density lipoprotein (HDL) cholesterol levels.

Two-in-one pill shows a reduction in plasma lipid levels and glucose levels.

The diabetes drug metaglidasen was shown to control blood glucose levels without causing weight gain or edema, according to a mid-stage clinical trial.

On Health of Medicaid Patients. The program is projected to reduce diabetes-related mortality by 9 percent and microvascular disease events by 15 percent among those who completed the program.

The CDC study found that the rate of people with diabetes admitted to a hospital for a potentially preventable reason fell 35 percent between 1994 and 2002. And the rate of kidney failure in diabetes patients has fallen about 30 percent since 1996.

Exubera, an inhaled insulin powder, worked as well in a study of 226 patients as injectable insulin.

Chromium picolinate reduced weight gain associated with anti-diabetes drugs and also improved blood sugar control and insulin sensitivity.

FDA Recalls the AccuSure Insulin Syringes made by Qualitest Pharmaceuticals, Inc.

Moderate-intensity exercise such as light continuous jogging or cycling poses a greater risk of hypoglycemia than intermittent high-intensity exercise representative of the activity patterns of team and field sports such as soccer or hockey.